Skip to main contentSkip to navigationSkip to search

Sustainability

Patients

Improving lives and efficient resource use with sustainable healthcare

With patients in focus, Camurus strives to reduce the impact of severe and chronic diseases, such as opioid dependence and rare diseases.

The goal is to be able to offer medicines with improved treatment outcomes, that provide an increased quality of life and a more efficient use of resources – thereby also contributing to a sustainable healthcare.

Material topics

Access to medicine

We aim to increase access to our products for as many people as possible. Camurus supports and collaborates with healthcare and patient organizations to reduce stigma and improve disease awareness – an important part of the work.

Read more about Camurus’ work to increase access

Product and patient safety

Product and patient safety is of highest priority, and Camurus follows and monitors marketed products for any product complaint and possible side effects. These are reported to health authorities in accordance with applicable laws and regulations.

Ethical clinical trials

Development of new medicines, both pre-clinical, e.g. animal testing, and clinical studies are conducted in accordance with applicable legislations, governing documents and quality system to steer for instance accurate and objective reporting, transparency, high ethics and patient integrity.

Read more about Camurus’ position on ethics in clinical trials

Our achievements

70,000 patients

estimated in treatment for opioid dependence at the end of 2025

 

Oczyesa®

Market authorization of in the EU and UK

Unitaid and PATH

Continued support of these actors enable access to opioid dependence treatment for a hepatitis C prevention project in several low- and middle-income countries. 

Access to medicines

Camurus aims to improve access to effective and convenient treatments for patients with severe and chronic diseases, such as opioid dependence and rare diseases. The goal is to increase access to treatments to potentially improve quality of life for as many people as possible.

Learn more about our work and approach 

Ethics in clinical trials

Camurus is determined to conduct clinical trials in an ethical manner. This includes protecting the safety, well-being and legal rights of all participants, and adhere to the highest ethical standards for clinical research.

Learn more about our work and approach

In-depth data

For more in-depth data on focus area patients see Camurus' Annual Report 2025

References

  1. Buvidal (Europe, Australia, MENA) by 2027.